Bibliographic citations
Mallqui, S., López, L. (2022). Factores internos del Perú que han influenciado en las estrategias de ingreso de empresas transnacionales del sector farmacéutico en el mercado peruano durante el período del 2007 – 2019 [Tesis, Universidad Peruana de Ciencias Aplicadas (UPC)]. http://hdl.handle.net/10757/659950
Mallqui, S., López, L. Factores internos del Perú que han influenciado en las estrategias de ingreso de empresas transnacionales del sector farmacéutico en el mercado peruano durante el período del 2007 – 2019 [Tesis]. PE: Universidad Peruana de Ciencias Aplicadas (UPC); 2022. http://hdl.handle.net/10757/659950
@misc{renati/1292216,
title = "Factores internos del Perú que han influenciado en las estrategias de ingreso de empresas transnacionales del sector farmacéutico en el mercado peruano durante el período del 2007 – 2019",
author = "López Torres Rivas, Luis Fernando",
publisher = "Universidad Peruana de Ciencias Aplicadas (UPC)",
year = "2022"
}
In recent years, the entry of companies from the pharmaceutical sector into Peru has presented a more than interesting increase, which has resulted in this sector, not only surviving the economic crisis but also increasing their profits. Income. Maintaining a growth between 3% and 4% for the following year (2020), according to the Peru Business portal. The objective of this research is to determine if factors of Peru have influenced the entry strategies of transnational companies in the pharmaceutical sector to the Peruvian market during the periods 2007 - 2019. Considering as dimensions the "Size of the market" (total sales and demand), "Growth Rate of the Economy" (GDP) and "Trade Agreements" (FTA, FTA, among others). For the development of this research work, the qualitative approach was applied with a phenomenological design. Likewise, for the collection of qualitative information, semi-structured interviews were carried out with 13 experts in the academic field and the pharmaceutical sector. These interviewees are representatives of private and public entities, representatives of ADIFAN, ALAFARPE, DIGEMID, representatives of pharmaceutical companies and representatives of multinational laboratories such as PFIZER, ABBOTT, ASTRAZENECA, among others. After that, these interviews were transcribed, coded and analyzed in the ATLAS.Ti. In addition to this, a contrast is made with the background to support the investigation The research work ends with the elaboration of conclusions and recommendations according to the specific objectives set, answering the research question and serving as a support tool for future research.
This item is licensed under a Creative Commons License